Press Release: Success Rates for Prostate Cancer Depend on Experience of Surgeondoi:10.1093/jnci/djm113Surgeons performing operations to remove patients' prostate glands—the primary treatment for prostate cancer—go through a steep learning curve, according to a study published online July 24 in the...
The success of treatment regimens promoting differentiation has not been explored for all acute myeloid leukemia (AML) subtypes. Here, the authors identify and characterize two lysine (K) deacetylase inhibitors promoting myeloid differentiation in all AML subtypes at low non-cytotoxic doses. ...
The reality about cancer treatment is well understood by Tang, the 26-year-old cancer patient who is himself a medical doctor. After surgery, the next course of action generally is chemotherapy or/and radiotherapy. Based on his note to his parents — these treatments cost a lot of money. B...
Two years later, Trastuzumab was introduced, becoming the first targeted therapy for breast cancer by targeting the HER2 protein,7 significantly impacting treatment strategies. The year 2001 saw another milestone with the FDA approval of Imatinib,8 the first kinase inhibitor, which revolutionized the t...
(MEDI-4736) was tested by a phase I/II trial in stage IIIB/IV NSCLC and other solid tumors. Durvalumab (10 mg/kg) was administered every two weeks for up to one year to treatment-naïve advanced NSCLC patients. The ORR was 25%, and the disease control rate was 56% with ≥ ...
Rates of PI trials were also higher among intergroup trials (68 of 131 [5.19%]; P = .003) and lower among blinded treatment trials (0 of 8; P = .009) and differed over time (P = .01), with the highest rate from 2000 to 2009 (33 of 55 [60.0%]). Fourteen ...
[134]. A controlled study compared the cure rates of low-risk SCC at one year by ED&C to those by surgical excision in a dermatological clinic at a Veterans Administration teaching hospital. A second study looked at the success rate of curettage and electrodesiccation for low- risk lesions ...
Survival Rates for Cervical Cancer The odds of surviving cervical cancer are tied to how early it's found. About 66% of women overall will survive for at least five years after diagnosis. But statistics don't predict how well any one individual will respond to treatment. ...
(3) effective treatment after early detection10,45. The overall impact in clinical practice depends on the success rates in each of these stages. This work addresses only the first stage. With a reasonably accurate method for predicting cancer risk, one can direct appropriate high-risk patients ...
Sequencing treatment strategies with different inhibitors have achieved initial success in CRPC. A phase II clinic trial has shown that using a sequencing strategy of abiraterone acetate followed by enzalutamide in CRPC patients provides a clinical benefit [157], although further exploration is needed ...